NEOTHYLLINE
LOE ApproachingNDAORALELIXIR
Approved
Mar 1951
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 21h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
NEOTHYLLINE is an oral elixir approved in 1951 as a branded small molecule product currently marketed by Teva. The drug's mechanism of action, therapeutic indications, and pharmacologic class are not publicly disclosed in available records. This legacy product represents a unique career opportunity in managing a mature, heritage brand with decades of clinical use.
LOE Approaching
LOE-approaching status with moderate competitive pressure (30/100) indicates the brand team is likely focused on portfolio transition strategy and cost-containment rather than growth initiatives.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
With zero linked job openings and LOE approaching, NEOTHYLLINE represents a maintenance-mode assignment rather than a growth opportunity. This role suits professionals seeking stable, established brand management experience or those transitioning into portfolio management and strategic discontinuation planning.
Brand ManagerRegional Sales Manager
Worked on NEOTHYLLINE at Teva? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.